The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Updated results of the GEST study: Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable advanced pancreatic cancer in Japan and Taiwan.
Akira Fukutomi
No relevant relationships to disclose
Takuji Okusaka
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Kazuya Sugimori
No relevant relationships to disclose
Hideki Ueno
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Tatsuya Ioka
Research Funding - Taiho Pharmaceutical
Shinichi Ohkawa
No relevant relationships to disclose
Narikazu Boku
Consultant or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Kenji Yamao
Consultant or Advisory Role - Taiho Pharmaceutical
Kazuhiro Mizumoto
Consultant or Advisory Role - Taiho Pharmaceutical
Junji Furuse
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Akihiro Funakoshi
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Takashi Hatori
No relevant relationships to disclose
Taketo Yamaguchi
No relevant relationships to disclose
Shinichi Egawa
No relevant relationships to disclose
Atsushi Sato
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Yasuo Ohashi
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Ann-Lii Cheng
Consultant or Advisory Role - TTY Biopharm
Masao Tanaka
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical